Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani-Reference-Cited by-同舟云学术

Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani

Published:2010-09-14 Issue:4 Volume:70 Page:609-617
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Kumar Awanish,Sisodia Brijesh,Misra Pragya,Sundar Shyam,Shasany Ajit Kumar,Dube Anuradha

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2010.03716.x/fullpdf

Reference40 articles.

1. Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites;Gazzinelli;Immunol Rev,2004

2. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic;Sundar;Clin Infect Dis,2000

3. Epidemiological, clinical and pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India;Thakur;Indian J Med Res,2004

4. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani;Wyllie;J Biol Chem,2004

5. Drug resistance in leishmaniasis;Croft;Clin Microbiol Rev,2006

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABC transporter inhibition by beauvericin partially overcomes drug resistance in Leishmania tropica;Antimicrobial Agents and Chemotherapy;2024-05-02

2. Antimony resistance and gene expression in Leishmania: spotlight on molecular and proteomic aspects;Parasitology;2023-11-28

3. Intramuscular Immunization with a Liposomal Multi-Epitope Chimeric Protein Induces Strong Cellular Immune Responses against Visceral Leishmaniasis;Vaccines;2023-08-19

4. Leishmania Proteomics: Insight into Diagnostics and Vaccine Development;Challenges and Solutions Against Visceral Leishmaniasis;2023

5. Heat Shock Proteins as Emerging Therapeutic and Vaccine Targets Against Leishmaniasis;Challenges and Solutions Against Visceral Leishmaniasis;2023